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Dead end (Dnd1) is an RNA-binding protein that mediates germ-cell viability and suppresses 
the formation of germ-cell tumors. Kedde et al. (2007) now provide evidence that Dnd1 
mediates these effects by counteracting microRNA-mediated silencing of mRNAs.Despite the fact that germ cells 
are specified through very differ-
ent mechanisms in various species, 
the genes that are required for their 
survival and further development 
appear to be remarkably similar. 
One such highly conserved gene 
encodes the RNA-binding protein 
Dead end (Dnd1). Dnd1 has been 
shown to regulate germ-cell viabil-
ity and suppress the formation of 
germ-cell tumors, yet how it exerts 1226 Cell 131, December 28, 2007 ©200mRNA translation and often affect 
the stability of the targeted mRNAs 
(Valencia-Sanchez et al., 2006). 
MicroRNAs carry out these effects 
by binding to homologous regions in 
the mRNA, usually in the 3′ untrans-
lated regions (UTRs) as part of a 
ribonucleoprotein complex named 
miRISC (Figure 1A). Voorhoeve et 
al. (2006) showed that miRNAs may 
act as oncogenes in human germ 
cells. In zebrafish, nanos and tdrd7 7 Elsevier Inc.are maternally derived mRNAs that 
are cleared from somatic cells by 
the miR-430 family (Mishima et al., 
2006). Yet, in germ cells, nanos and 
tdrd7 mRNAs persist despite the 
presence of miR-430. Kedde et al. 
now establish a mechanism that 
connects these two observations by 
revealing a role for Dnd1 in repress-
ing miRNA-mediated silencing.
Using cell culture-based assays 
the authors find that Dnd1 is able to these effects has remained 
unresolved. Work by Kedde 
et al. (2007) presented in this 
issue of Cell now suggests that 
by binding to target mRNAs, 
Dnd1 blocks their interaction 
with microRNAs (miRNAs) and 
thereby protects mRNAs from 
miRNA-mediated repression.
Dnd1 was first characterized 
as a gene required for germ-cell 
viability in a large-scale screen 
in zebrafish aimed at identifying 
mRNAs that are specifically found 
in germplasm (also known as 
nuage), a granular structure char-
acteristic of germ cells (Weidinger 
et al., 2003). Following this, a pre-
mature stop codon in Dnd1 was 
identified in Ter mutant mice, 
which display germ-cell loss in 
addition to a high frequency of 
testicular germ-cell tumors in one 
genetic background (Youngren et 
al., 2005). Yet, apart from the fact 
that Dnd1 most likely affected 
some aspect of RNA biology, a 
molecular understanding of Dnd1 
function was completely lacking.
Increasing evidence suggests 
that miRNAs play an impor-
tant role in germ-cell biology. 
In general, miRNAs silence Figure 1. Dnd1 Promotes mRNA Stability
(A) MicroRNAs (miRNAs) are part of a multisubunit 
complex, often referred to as miRISC. This complex 
can bind to mRNAs when a region in the mRNA (blue 
box) is homologous to the miRNA. MicroRNAs in-
hibit translation and decrease the stability of target 
mRNAs. 
(B) When the Dnd1 protein binds to a U-rich region in 
the mRNA (orange box), it can block recognition of the 
mRNA by miRISC, allowing translation of the mRNA. 
(C) Alternatively, Dnd1 may translocate the bound 
mRNA to structures that are inaccessible to miRISC, 
such as the germplasm of germ cells.elevate the expression of reporter 
genes carrying 3′UTRs of the 
genes encoding the tumor sup-
pressors LATS2 and p27. Previ-
ous work showed that miR-372 
and miR-373 may act as onco-
genes in germ cells by targeting 
the LATS2 3′UTR (Voorhoeve et 
al., 2006). Importantly, the ability 
of Dnd1 to elevate expression of 
these reporters depends on the 
presence of a functional miRNA-
binding site in the reporter (miR-
372 in the case of the LATS2 
reporter and miR-221 for the p27 
reporter). Agami and colleagues 
then go on to show that Dnd1 
binds to U-rich regions that are 
located close to the miRNA rec-
ognition sites in the p27 3′UTR. 
Without these U-rich regions 
Dnd1 cannot affect miRNA 
action. Yet, the LATS2 3′UTR 
does not have a clearly recog-
nizable U-rich region and still is 
affected by Dnd1.
Importantly, the authors 
extend their findings to settings 
where endogenous Dnd1 protein 
could be analyzed. They show 
that Dnd1 is required in zebrafish 
for the remarkable resistance of 
nanos and tdrd7 mRNA to miR-
430. Also, in these cases, the miR-
NA-binding site is flanked by a U-rich 
region that is required for Dnd1 to 
function. Does this fully explain the 
germ-cell defects observed upon 
knocking down Dnd1 in zebrafish? 
This remains an open question, as 
the experiment required to test this 
has not been done: if the germ-cell 
defects that arise when Dnd1 is 
knocked down are due to miRNA-
mediated silencing, then taking 
away Dicer, a key enzyme in miRNA 
generation, should rescue the germ-
cell defect inflicted by loss of Dnd1. 
The authors also found that Dnd1 
protects LATS2 from being targeted 
by miR-372 in a human teratoma-
derived cell line (Tera1). In fact, miR-
372 is highly expressed in many tes-
ticular germ-cell tumors (Voorhoeve 
et al., 2006). Hence, overexpression 
of miR-372 may be selected dur-
ing tumorigenesis to overcome the 
inhibitory effect of Dnd1. Unfor-
tunately, an extensive correlation 
between the presence of Dnd1 and 
miRNA expression in these tumors 
is not available at the moment.
Together, these results strongly 
suggest that endogenous Dnd1 
affects miRNA-mediated repres-
sion of specific mRNAs. How does 
Dnd1 do this? As the authors show 
that Dnd1 prevents the associa-
tion of miR-221 with the p27 3′UTR, 
there are at least two possibilities 
that come to mind, which are not 
mutually exclusive (Figure 1). First, 
Dnd1 may physically block access 
to an miRNA target site. In fact, the 
U-rich regions in the nanos and 
tdrd7 3′UTRs are located directly 
5′ of the miR-430 seed match (the 
seed match is the most 5′ part of 
the miRNA, which is very important 
for target-site recognition). Although 
pairing between the miRNA and the 
bases upstream of the seed match may not be required for miRNA activ-
ity, it seems likely that miRISC will be 
sterically hindered by a protein bind-
ing to that region. However, Kedde 
et al. also show that a single U-rich 
region in the 3′UTR of p27 that is not 
directly flanking an miRNA target site 
can still prevent miRNA-mediated 
silencing. Clearly, at present, we 
know too little about the structural 
aspects of both miRISC target rec-
ognition and Dnd1 binding to RNA to 
address these issues. Another pos-
sibility is that Dnd1 may change the 
subcellular localization of an mRNA, 
taking it out of reach of miRNAs. In 
agreement with this, Dnd1 localizes 
to discrete perinuclear granules in 
primordial germ cells (Weidinger et 
al., 2003). Although the absence of 
antibodies to Dnd1 has prohibited 
analysis of its subcellular distribution 
during early embryogenesis, it may, 
like the nanos and tdrd7 mRNAs, also 
localize to germplasm at the early 
cleavage stages of zebrafish devel-
opment. Whether these mRNAs are 
translated at that time is not clear, 
but in general these granular struc-
tures are thought to be repressive 
in nature. Later, when the germ-cell 
precursors have reached the future 
gonad, nanos and tdrd7 mRNAs 
become cytoplasmic. Around this 
time miR-430 levels drop (Giraldez 
et al. 2005) and storage of these 
mRNAs in protective structures may 
no longer be required.
As 3′UTRs of mRNAs are targeted 
by numerous RNA-binding pro-
teins, only one of which is miRISC, 
it is not surprising to see evidence 
accumulating that miRNA-mediated 
silencing is tuned by RNA-binding 
proteins that are not directly part of 
the miRNA complex. For example, 
the RNA-binding protein HuR can 
relieve miRNA-mediated repression 
in human hepatocarcinoma cells Cell 131, Dec(Bhattacharyya et al., 2006), and 
miRNA activity at synapses appears 
to be regulated in a similar manner 
(Schratt et al., 2006; Ashraf et al., 
2006). It was only a matter of time 
before we would hit upon modula-
tors of miRNAs that may have medi-
cal relevance. Kedde et al. have 
shown that such endeavors have 
surely not met a dead end.
AckNowlEDgMENtS
I thank F. Steiner for critical reading of this 
manuscript.
REFERENcES
Ashraf, S.I., McLoon, A.L., Sclarsic, S.M., and 
Kunes, S. (2006). Cell 124, 191–205.
 Bhattacharyya, S.N., Habermacher, R., Mar-
tine, U., Closs, E.I., and Filipowicz, W. (2006). 
Cell 125, 1111–1124.
Giraldez, A.J., Cinalli, R.M., Glasner, M.E., 
Enright, A.J., Thomson, J.M., Baskerville, S., 
Hammond, S.M., Bartel, D.P., and Schier, A.F. 
(2005). Science 308, 833–838.
Kedde, M., Strasser, M.J., Boldajipour, B., 
Oude Vriellink, J.A.F., Slanchev, K., le Sage, 
C., Nagel, R., Voorhoeve, P.M., van Duijse, J., 
Andersson Ørom, U., et al. (2007). Cell, this is-
sue.
Mishima, Y., Giraldez, A.J., Takeda, Y., Fuji-
wara, T., Sakamoto, H., Schier, A., and Inoue, 
K. (2006). Curr. Biol. 16, 2135–2142.
Schratt, G.M., Tuebing, F., Nigh, E.A., Kane, 
C.G., Sabatini, M.E., Kiebler, M., and Green-
berg, M.E. (2006). Nature 439, 283–289.
Valencia-Sanchez, M.A., Liu, J., Hannon, 
G.J., and Parker, R. (2006). Genes Dev. 20, 
515–524.
Voorhoeve, P.M., le Sage, C., Schrie, M., Gillis, 
A.J.M., Stoop, H., Nagel, R., Liu, Y., van Dui-
jse, J., Drost, J., Griekspoor, A., et al. (2006). 
Cell 124, 1169–1181.
Weidinger, G., Stebler, J., Slanchev, K., 
Dumstrei, K., Wise, C., Lovell-Badge, R., 
Thisse, C., Thisse, B., and Raz, E. (2003). Curr. 
Biol. 13, 1429–1434.
Youngren, K.K., Coveney, D., Peng, X., Bhat-
tacharya, C., Schmidt, L.S., Nickerson, M.L., 
Lamb, B.T., Deng, J.M., Behringer, R.R., Ca-
pel, B., et al. (2005). Nature 435, 360–364.ember 28, 2007 ©2007 Elsevier Inc. 1227
